Information on how to access prescribing information and adverse event reporting can be found at the bottom of this page.
Scientific advances in understanding cancer, coupled with innovative treatment breakthroughs, mean that cancer care has been transformed in recent years, and more people than ever will survive the disease.1
At Pfizer, we are committed to the discovery and development of pioneering therapies that continue to improve the outlook for cancer patients. Over the past decade, we've taken bold new approaches to translate innovative scientific research into meaningful breakthrough medicines for people living with cancer. And we won't stop there.
We're striving to advance the frontiers of cancer biology to develop a new generation of cutting edge therapies, across multiple cancers and tumour types for which an unmet need exists. Each day, our scientists are working towards discovering new breakthroughs that could save lives.
Our pipeline includes biologics, small molecules, immunotherapies and biosimilars, and is centred on exploring a multitude of approaches across many tumour types.
We are focused on exploring genetic, phenotypic, and functional biomarkers to help guide clinical research strategies and ensure the right patients are treated with the right medicines. Our goal is to develop therapies with potentially transformational outcomes.
Specific area of interest include:
Bavencio®▼ (avelumab) + axitinib aRCC
Bavencio®▼(avelumab) MCC & UC
Besponsa®▼ (inotuzumab ozogamicin)
Mylotarg®▼ (gemtuzumab ozogamicin)
Ruxience®▼ (rituximab)
Trazimera®▼ (trastuzumab)
Zirabev®▼ (bevacizumab)
1. Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer 2012; 107 (7):1195-202.
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
Add indication message here. It can link a link,
and you can EMBOLDEN text
OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?